Robert B. Ebbeling is President & Operations at HAEMONETICS CORP (HAE). They have made 9 open-market trades across 1 company since 2006, most recently 2009-05-01.
CIK 0001221863
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $81K since 2006, against 3 sales. Across 6 scored buys the stock is down 2.0% at ninety days, and 2.3 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| HAE | 15,849 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2009-05-05 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -4.4% | -2.0% | -2.0% |
| Alpha | +1.4% | -2.3% | -2.3% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HAE | BUY | 2009-05-01 | 2009-05-05 | $43.89 | $19K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2008-09-09 | 2008-09-10 | $65.00 | $1.4M | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2008-09-08 | 2008-09-10 | $65.00 | $1.4M | -4.4% | -2.0% | -2.0% |
| HAE | BUY | 2008-05-01 | 2008-05-06 | $44.35 | $21K | -4.4% | -2.0% | -2.0% |
| HAE | BUY | 2007-11-01 | 2007-11-05 | $40.66 | $6K | -4.4% | -2.0% | -2.0% |
| HAE | BUY | 2007-05-01 | 2007-05-03 | $38.63 | $15K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2007-02-13 | 2007-02-15 | $47.01 | $578K | -4.4% | -2.0% | -2.0% |
| HAE | BUY | 2006-11-01 | 2006-11-03 | $38.76 | $7K | -4.4% | -2.0% | -2.0% |
| HAE | BUY | 2006-05-01 | 2006-05-02 | $41.52 | $13K | -4.4% | -2.0% | -2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.